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ABSTRACT 
Mitochondrial cytochrome c is associated with electron transfer in the respiratory chain and in 
apoptosis. Four cytochrome c variants have been identified in families that suffer from mild 
autosomal dominant thrombocytopenia, a platelet disorder associated with increased apoptosis. 
Three out of the four substitutions, G41S, Y48H and A51V are located on the 40-57 Ω-loop. 
The G41S and Y48H variants perturb key physicochemical and dynamic properties that result 
in enhanced functional features associated with apoptotic activity. Herein we characterise the 
ferric A51V variant. We show by chemical denaturation that this variant causes the native state 
to be destabilized. Through azide binding kinetics, the population of a pentacoordinate heme 
form, whereby the Met80 axial ligand is dissociated, is estimated to be of equal magnitude to 
that found in the Y48H variant. This pentacoordinate form gives rise to peroxidase activity, 
which despite the similar pentacoordinate population of the A51V variant to that of the Y48H 
variant, the peroxidase activity of the A51V variant is supressed. Far-UV circular dichroism 
spectroscopy and pH jump studies, suggest that a combination of structural and dynamic 
features in addition to the population of the pentacoordinate form regulate peroxidase activity 
in these disease variants. Additionally, the steady-state ratio of ferric/ferrous cytochrome c 
when in turnover with cytochrome c oxidase has been investigated for all 40-57 Ω-loop 
variants. These studies show that the lower pKa of the alkaline transition for the disease causing 
variants increases the ferric to ferrous heme ratio, indicating a possible influence on respiration 
in vivo.  
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INTRODUCTION 
Mitochondrial cytochrome c (Cc) is a key protein in the life and death processes of a eukaryotic 
cell. In humans, it is now widely recognised that Cc has an extensive repertoire of roles ranging 
from acting as an electron shuttle in oxidative phosphorylation to roles in apoptosis, redox 
signalling, as an inhibitor of histone chaperone activity and an involvement in the 
mitochondrial oxidative folding machinery.[1-4] These multiple functions have led to Cc being 
branded as an extreme multifunctional (EMF) protein.[5, 6]  
 Cc possesses a hexacoordinate heme, with axial heme iron coordination derived from 
the Nδ1 atom of His18 and the Sγ atom of Met80.[7] The c-type heme is bound to the 
polypeptide through a CXXCH motif within a fold that comprises of five α-helices, and three 
Ω-loops[7] (structural motifs with residues at the start and end of the loop close in space [8, 
9]). Embedded in the EMF persona of Cc is its ability to access energetically favoured 
conformational states above its ground state native structure.[5] Under physiological 
conditions the ferric form of Cc exists in an equilibrium between the dominant hexacoordinate 
form and a minor populated pentacoordinate state, in which the Met80 ligand is dissociated 
from the heme iron.[7] Despite the pentacoordinate population being exceedingly low, it is 
sufficient to confer peroxidase activity,[10-15] which has implications for apoptotic activity, 
in particular when Cc is complexed with the phospholipid cardiolipin (CL).[16-24]  
At alkaline pH, ferric Cc can access a conformational state whereby a deprotonation of 
a group within a hydrogen bonded network of amino acid side chains and a heme propionate 
causes dissociation of the Met80 ligand [25] and subsequent coordination to the heme iron by 
a Lys residue from the 71-85 Ω-loop.[25-28] This transition is commonly referred to as the 
alkaline transition and when measured under equilibrium conditions has an apparent pKa of ~ 
9 depending on solution conditions and Cc species.[7, 29, 30] A common feature in formation 
of these non-native conformers of ferric Cc is a dynamic communication between the 40-57 
and 71-85 Ω-loops.[5, 25, 31, 32] These two structural units have been shown to possess the 
lowest free energy out of the five cooperative folding/unfolding units (foldons) assigned in Cc, 
with the 40-57 Ω-loop having the lowest stability.[33-36] Furthermore, the Fe(III)-Sγ(Met80) 
bond strength, a key regulator to accessing the non-native states, is influenced by an entatic 
contribution of the protein derived through a hydrogen bonding network that communicates 
between the two Ω-loops.[37] Perturbation of this hydrogen bonding network diminishes the 
entatic control and enhances Met80 dissociation.[25, 37]  
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Four pathogenic mutations in the human Cc gene have been identified in families that 
suffer from mild autosomal dominant thrombocytopenia (THC4; OMIM 612004); a disorder 
caused by dysregulated platelet formation associated with increased mitochondrial 
apoptosis.[38-41] Three of the mutations are missense and give rise to the G41S, Y48H and 
A51V variants found in the 40-57 Ω-loop,[38-40] with the fourth an in-frame deletion that 
results in a variant whereby Lys100 in the C-terminal α-helix is deleted[41] (Fig. 1). The G41S 
variant possesses enhanced apoptotic activity in vitro,[38] with subsequent studies providing 
further insights into the physicochemical properties inherent in this variant attributing to 
enhancing apoptotic activity.[23, 24, 31, 42, 43] Of particular note is an increased population 
of the pentacoordinate heme form under non-denaturing conditions.[23, 31] Enhanced 
apoptotic activity of the Y48H variant was initially reported,[39] with a more detailed in vitro 
characterisation revealing the Y48H variant to have substantially higher peroxidase activity 
than the G41S variant, attributed to the equilibrium between the hexacoordinate and 
pentacoordinate heme forms being shifted further towards the pentacoordinate state.[5] 
Solution NMR spectroscopy studies on these variants demonstrated that main chain dynamics 
were enhanced compared to wild-type (WT) human Cc (hCc).[5, 31] Notably, the dynamic hot 
spots are centred around the 40-57 and 71-85 Ω-loops with a dynamic hierarchy of Y48H > 
G41S > WT, which currently scales with the population of the pentacoordinate species 
associated with peroxidase activity.[5, 31]  
 In the present study we have prepared the A51V variant to ascertain the properties this 
mutation infers on the functional properties of hCc and to place the findings in context with 
our previous studies with the G41S and Y48H variants.[5, 25, 31] We have performed a suite 
of experiments designed to probe the pentacoordinate form of the native state that gives rise to 
the peroxidase activity. We find that the A51V variant has a relatively mild effect on the 
physicochemical properties of hCc. However, despite the population of the pentacoordinate 
heme species being enhanced, the peroxidase activity remains supressed compared to the G41S 
and Y48H variants. Furthermore, we have investigated the effects of the three 40-57 Ω-loop 
variants on the redox state of hCc in steady-state turnover with cytochrome c oxidase (CcO). 
In these turnover experiments the redox state of hCc was affected by the nature of the 
substitution, with Y48H having the larger effect and the A51V the least.  
 
MATERIALS AND METHODS 
Construction of the A51V hCc variant 
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The A51V variant of hCc was constructed using the Quikchange mutagenesis (Stratagene) 
protocol with the pUC19hCc plasmid as template.[23] The forward and reverse mutagenic 
primers were as follows: 5’-CTCTTACACAGCCGtgAATAAGAACAAAG 3’ and 5’- 
CTTTGTTCTTATTcaCGGCTGTGTAAGAG-3’, respectively, with the mutation sites in 
lower case. A PCR mix consisting of primers (75 ng/µl), pUC19hCc (15 ng/µl), 10 mM dNTPs 
(Fermentas), Pfu (Pyrococcus furiosus) Turbo polymerase (Agilent), 10x polymerase buffer 
(Agilent) and deionised water to give a final volume of 50 µl and subjected to the following 
PCR cycle; 95 °C – 3 min, (95 °C – 1 min, 65 °C – 1 min, 72 °C – 6 min) x 18, 72 °C – 10 
min. PCR products were digested with the restriction enzyme DpnI (Fermentas) and 
transformed into Escherichia coli XL1-Blue (Agilent) cells. DNA sequencing was used to 
confirm the presence of the desired nucleotide changes (Source BioScience, UK).  
 
Over-expression of hCc and variants 
Over-expression of WT hCc, the G41S, Y48H and A51V variants was carried out in E. coli 
strain BL21(DE3)-RIL (Agilent) with isolation and purification of all proteins as reported 
previously.[23]  
 
Isolation and purification of bovine CcO 
A fresh bovine heart was obtained from C.J. Byford & Sons (Clacton-on-Sea, U.K.) and CcO 
was isolated according to a previously reported procedure.[44] The pure CcO, as judged by the 
absorbance ratio 445/420 nm in the reduced state of > 2.5, was aliquoted and stored in 100 mM 
potassium phosphate, pH 7.4, 1% Tween80 (Sigma-Aldrich) at -80 oC until required. 
 
Protein preparation 
Oxidized Cc proteins were prepared by the addition of excess K3[Fe(CN)6], followed by 
removal of K3[Fe(CN)6] and K4[Fe(CN)6] and exchanged into a desired buffer using a PD-10 
column (GE Healthcare). Protein concentrations were determined using a Cary 60 
spectrophotometer (Agilent). Molar extinction coefficients (ε) were determined for ferric WT 
hCc and variants using a pyridine hemochromogen assay[45] and are reported in Table S1. 
Aliquots of CcO were thawed and spun for 2-3 min at high speed in a micro-centrifuge. The 
absorbance peak at 605 nm (ε = 21,000 M-1 cm-1) in the reduced CcO samples arising from 
heme a was used to determine sample concentration. All CcO concentrations are expressed in 
terms of heme a concentration.  
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Far-UV circular dichroism spectroscopy and chemical denaturation  
Far-UV circular dichroism (CD) spectroscopy was carried out using an Applied Photophysics 
Chirascan CD spectrophotometer (Leatherhead, UK) thermostatted at either 15 or 20 oC. Ferric 
protein samples (18-26 µM) were prepared in 10 mM potassium phosphate, 50 mM potassium 
fluoride pH 6.5 and a wavelength scan between 190-250 nm was conducted. To determine 
protein stability, a 6 M stock solution of guanidine hydrochloride (GuHCl) (Fluka) was 
prepared in the identical buffer and titrated into a ferric A51V variant sample. Changes in molar 
ellipticity at 222 nm (θ222nm) were monitored and the free energy of unfolding (∆Gunf) and 
dependence of ∆Gunf on denaturant concentration (m-value) were calculated using equation 1 
[46] 
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where αN and αD correspond to the baseline values of the native and denatured protein at 0 M 
GuHCl respectively, and βN and βD to their respective dependence on [GuHCl] i.e. the slope. 
∆Gunf is the free energy of denaturation in water and m represents the dependence of the free 
energy of denaturation on [GuHCl]. To represent the data in terms of fraction denatured (FD) 
at any given [GuHCl] equation (2) was used.[47] 
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All titrations were carried out in triplicate with the errors reported the standard error. 
 
Alkaline pH titrations 
The pH dependence of the 695 nm band in the electronic absorption spectrum of the ferric 
A51V hCc variant (100 µM) was monitored at 25 oC by determining the absolute absorbance 
at various values of pH in the presence of a small aliquot of K3[Fe(CN)6] to maintain an 
oxidising environment. The pH of the buffer (20 mM sodium phosphate pH 6.0) was adjusted 
with microliter aliquots of 1 M NaOH and measured after each addition using a semi-micro 
glass pH electrode. pH titrations were repeated three times and with different batches of 
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proteins. Data were fitted to a one-proton ionization equilibrium equation to yield an apparent 
pKa. 
 
Peroxidase assays 
The oxidation of 2,2-Azinobis(3-ethylbenthiazoline-6-sulfonic acid) (ABTS; Fisher) was 
monitored at 730 nm on a Hewlett-Packard 8453 diode-array spectrophotometer scanning 
between 190 and 1100 nm and thermostatted at 20 oC. The reaction was initiated by the addition 
of 1 mM H2O2 (after 40 s) to a series of cuvettes containing 5 µM of the ferric A51V variant 
and 200 µM ABTS. Using the wavelength pair 475-730 nm the slope of each trace (post-lag 
phase) was determined to obtain a rate in AU/s. The turnover rate is reported in s-1 obtained by 
dividing AU/s by the product of the concertation of oxidized ABTS (ε = 14 mM-1 cm-1) and 
the total protein concentration (5 µM). All assays were carried out in triplicate with errors 
reported as the standard error. 
 
Azide binding kinetics 
An Applied Photophysics (Leatherhead, UK) SX20 stopped-flow spectrophotometer 
thermostatted at 25 oC and equipped with both photomultiplier and diode array detection 
systems was used to monitor rapid reaction kinetics. A stock solution of 2 M sodium azide (N3
– 
; Sigma-Aldrich) was buffered in 50 mM 2-(N-morpholino)ethanesulfonic acid (MES) pH 7.0 
and diluted to the desired [N3
–] with the same buffer containing 2 M NaCl to maintain the ionic 
strength. Reaction time-courses were taken at 420 nm with [N3
–] varying between 0.08 and 2 
M (before mixing) and 10 µM protein (before mixing). All transients were fitted to a single 
exponential function yielding both pseudo first-order rate constants and amplitudes. Assuming 
N3
– binding to ferric Cc is an SN1 mechanism, in which the hexacoordinate heme form is in 
equilibrium with a pentacoordinate form, the latter being the form that binds N3
–, then, as 
outlined previously,[31] equations 3 and 4 may be derived that describe the Kapp and the 
dependence of kobs for N3
– binding as a function of [N3
–]. 
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In these equations, K = k1/k-1, where k1 and k-1 are the rate constants for Met80 dissociation and 
association respectively and KD = k-2/k2, with k2 the pseudo-first order rate constant for N3
– 
binding i.e. k2 = k'[N3
–], where k' is the second order rate constant and kobs is ~ k1 at high [N3
–
]. The data for the A51V and Y48H variants were not collected over a sufficiently wide range 
to allow for the fitting algorithm to converge and yield values for the three parameters defining 
equation 4. However, convergence was achieved to yield values of k-2 (the intercept on the 
ordinate), which was then fixed and not allowed to vary, to determine k1 with its associated 
errors. In addition calculation of k1 using either the upper or lower bound error for k-2 were 
used and these values are discussed in the footnote to Table 2. 
 
pH jump kinetics 
For pH jumping experiments a range of pH buffers containing 50 mM KCl, 50 mM boric acid 
(pH 7 - 9) or 50 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) (pH 9 - 13) were 
prepared and stocks of the ferric A51V variant prepared in H2O and diluted to experimental 
concentrations in 50 mM KCl, to maintain ionic strength during mixing, to a pH of ~ 7. pH 
jump experiments were initiated in a stopped-flow spectrophotometer by mixing solutions of 
the ferric A51V variant with an equal volume of high pH buffer. First order rate constants (kobs) 
were obtained by fitting reaction time-courses to either a single exponential at pH values 
between 8.5 and 10 (kobs1 slow phase) or at pH values above 10.5 a double exponential function 
(kobs1 and kobs2 fast phase). Experiments were repeated in triplicate and with different protein 
batches with errors reported the standard error. All kinetic analysis was conducted using the 
software ProKineticist (Applied Photophysics).  
 
Turnover experiments using cytochrome c oxidase 
Kinetic experiments were carried out using a stopped-flow spectrophotometer operating in 
photo diode array mode. CcO (5 µM), ferric h Cc (20 µM), sodium ascorbate (10 mM; Sigma-
Aldrich) and the redox mediator N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD 
concentrations ranging between 100 to 600 µM; Fisher) were dissolved in 0.1 M sodium 
phosphate buffer, pH 7.4, containing 1% Tween 80 (Sigma-Aldrich). This solution rapidly 
exhausts the oxygen present in solution and fully reduces both the Cc and CcO (cyt aa3 CuA 
CuB) before rapidly mixing with aerobic buffer (~270 µM oxygen as determined from the 
solubility coefficient using the temperature and pressure on the day). On mixing, the reduced 
CcO is fully oxidised within the dead time of the stopped-flow (~ 1.5 ms) and thereafter a 
sequence of reactions occur (see Results) that leads eventually to the complete depletion of 
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oxygen and the return of the system to the fully reduced state. The excursions of the spectral 
absorption bands associated with the chromophores present were followed using a diode array 
accessory and time courses and levels of reduction in steady-state monitored. 
 
RESULTS 
Far-UV CD spectroscopy of the ferric A51V variant and comparison with the G41S and Y48H 
hCc variants 
The far-UV CD profile for ferric hCc is shown in Figure 2A, with the characteristic minima at 
208 and 222 nm consistent with a fully folded protein dominated by α-helical structure. The 
ferric A51V variant displays a similar profile, as do the G41S and Y48H variants, confirming 
in the first instance that on purification the A51V variant is folded (Fig. 2A). No differences in 
the far-UV CD profiles for the WT or any of the variants in a temperature range between 10 
and 30 oC were observed (data not shown). The X-ray structures of the three variants, [5, 42, 
48], reveal no significant secondary structure differences in respect to the WT structure.[23] In 
contrast, solution NMR studies indicate that the G41S and Y48H variants are more dynamic 
than the WT protein.[5, 31] In this respect, we note that the θ222/208 nm ratio between the variants 
varies from the WT protein (Fig. 2A). For the WT protein, the θ222/208 nm ratio is 1.3, with a 
value of 1.1 determined for the G41S and A51V variants and the Y48H variant having a ratio 
of 0.9. For a globular α-helical protein, perturbations to the θ222/208 nm ratio can be associated 
with changes in interhelical interactions resulting from changes to the packing of Trp side 
chains within a protein core [49]. In Cc, Trp59 has a key role in the packing of the Cc 
hydrophobic core.[50] Therefore, the θ222/208 nm ratio hierarchy (WT > G41S ≅ A51V > Y48H) 
may infer differences in packing around Trp59, arising from the increased global dynamics 
reported from NMR studies for the G41S and Y48H variants,[5, 31] and therefore a similar 
increase in dynamics could be anticipated for the A51V variant.  
 
Global stability of the ferric A51V hCc variant 
The thermodynamic unfolding parameters for the ferric A51V variant were obtained by 
monitoring the decrease in θ at 222 nm in the far-UV CD spectrum upon titration with GuHCl. 
The conditions employed (pH 6.5 and 15 oC) were identical to those used previously for the 
G41S and Y48H variants for which the free energy changes were used in conjunction with 
NMR H/D-exchange data collected at 15 oC.[5] Table 1 reports the ∆Gunf, m-value and Cm 
values for the ferric A51V variant and a plot of the fraction unfolded versus [GuHCl] is shown 
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in Fig. 2B. It is apparent from Table 1, that the global stability of the ferric A51V variant 
follows a similar trend to both the G41S and Y48H variants, in that the cooperativity of 
unfolding (m-value) decreases, leading to a decrease in the ∆Gunf, with respect to WT hCc. As 
noted previously,[5] the introduction of a His residue in the Y48H variant has connotations to 
the possibility of it competing with His26 and His33 in ligating to the heme iron in the 
denatured state. Therefore, a comparison of the stability (∆∆Gunf) amongst the three variants is 
made using GuHCl at a pH where additional competing misligation in the denatured state for 
the Y48H protein is a possibility (Table 1). However, from the ∆∆Gunf a hierarchy of global 
stability for the 40-57 Ω-loop variants of WT >> A51V ≅ G41S >> Y48H is observed, with a 
parity between the A51V and G41S variants and the Y48H variant being the outlier. 
 
Effect on the local stability of the 71-85 Ω-loop imposed by the A51V hCc variant 
From previous work with the ferric G41S and Y48H variants, we have shown that mutations 
in the 40-57 Ω-loop influence the structural dynamics of the Met80-containing Ω-loop, with 
consequences for the Fe(III)-Sγ(Met80) bond lability.[5, 31] Our preference has been to 
investigate the local dynamics of the 71-85 Ω-loop by using the kinetics of N3– binding.[5, 25, 
31] Such experiments provide an insight into the population of the pentacoordinate heme form 
i.e. the Met80-off form that binds N3
– and gives rise to the intrinsic peroxidase activity. Upon 
mixing N3
– with the ferric A51V variant, an optical transition occurs caused by dissociation of 
the Met80 ligand from the heme iron and binding of N3
– in its place.[31] The reaction time-
course of this transition for the A51V variant conformed to a simple exponential as reported 
for other hCc variants under identical experimental conditions. [5, 25, 31] The normalised 
amplitudes of the reaction time-courses over a broad range of [N3
–] follows a simple hyperbolic 
relationship, enabling an apparent equilibrium constant (Kapp) for N3
– binding to be determined 
(Fig. 3A). The Kapp for the ferric A51V variant is reported in Table 1, together with Kapp values 
for the ferric forms of the G41S and Y48H variants.[5, 31] Notably, the A51V variant has a 
Kapp identical to the Y48H variant. The relationship between the rate constant for N3
– binding 
(kobs) and [N3
–] given in equation 4 should conform to a hyperbola, where a curve is expected 
to reach a plateau (i.e. k1, the Met80 ligand dissociation rate constant). As previously discussed 
for WT hCc and the G41S and Y48H variants this is not the case under the conditions 
employed, as a suitably high [N3
–] cannot be explored.[5, 25, 31] Earlier work using linear 
fitting procedures used reciprocals to obtained k1 values of 30 s
-1 for horse heart Cc using N3
– 
as the competing ligand.[51] Refitting of this earlier data using equation 4 (non-linear fitting) 
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gives a value of between 11-16 s-1 for horse heart Cc [31] which is comparable to that of WT 
hCc (Table 1). A non-linear fit to the data for the A51V variant is shown in Figure 3B and 
yields the k1 and k-2 values reported in Table 1. A comparison of the k1 and k-2 values reported 
previously for the WT, G41S and Y48H variants reveals the k1 of the Met80 ligand for the 
A51V variant is elevated above the WT hCc and lies closer to the G41S variant, rather than the 
Y48H variant (Table 1). 
 Equation 3 shows that when K < 1, as seen here, because the concentration of the 
pentacoordinate species is low, then Kapp is ~ KD/K. Based on the assumption that N3
– binding 
to the pentacoordinate heme species is not influenced directly by the different substitutions in 
the protein other than by the provision of pentacoordinate ferric heme, then KD will be similar 
for all proteins in Table 1, so that the ratio of Kapp values in 
WTKapp/
variantKapp, reflects the ratio 
of K values variantK/WTK and therefore is indicative of the relative proportions of the 
pentacoordinate heme state. We have justified the assumption that the heme in the WT hCc 
and variants have the same intrinsic KD in our previous work and have proposed that the 
differences between the WT and variants reflect the different extent to which the protein matrix 
cages the heme group from the approach of the ligands.[25] This justification is based on the 
fact that the measured off-rate of the N3
– (k-2) and the Met80-off rate (k1) for the disease 
variants conforms to a hyperbola, asymptotic to 11.8 ± 0.6 s-1 (Fig. 3C). As this value is only 
reached when Met80 is essentially dissociated it constitutes the intrinsic dissociation rate 
constant, k-2 intrinsic, of N3
– dissociating from the heme in these hCc variants. As the A51V 
variant falls neatly on the same hyperbolic relationship we conclude this variant likewise has 
the same intrinsic KD (Fig. 3C). Therefore based on these previous arguments,[25] the A51V 
variant has a pentacoordinate heme state populated to essentially the same extent as the Y48H 
variant as determined from N3
– binding kinetics (i.e. variantK/WTK). 
 
Peroxidase activity of the A51V hC c variant 
The intrinsic peroxidase activity of Cc arises from the existence of an equilibrium in the ferric 
heme state between the hexacoordinate Met80-bound form and a pentacoordinate Met80-off 
form, with the latter being peroxidase active.[7, 10-15] In the early stages of apoptosis, CL 
complexes with Cc, resulting in the pentacoordinate form becoming dominant, enabling 
oxidation of CL to occur.[16] A feature of the 40-57 Ω-loop variants has been their increased 
intrinsic peroxidase activity relative to WT hCc.[5, 23, 24] Under identical assay conditions to 
previous studies with the G41S and Y48H variants,[5] the A51V variant is capable of oxidizing 
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ABTS in the presence of H2O2, with a turnover lower than that of the G41S variant, but greater 
than for the WT protein (Fig. 4). Notably, the apparent equivalent population of the 
pentacoordinate species for the A51V and Y48H variants deduced from N3
– binding kinetics 
does not manifest itself in the intrinsic peroxidase activity of these two variants (Fig. 4), with 
the A51V variant having peroxidase activity closer to the WT and G41S variant than the Y48H 
variant. 
 
Alkaline isomerisation and pH jump kinetics of the ferric A51V hCc variant 
The 695 nm absorbance band in the electronic absorption spectrum of ferric hCc reports on the 
presence of the Met80(Sγ)-Fe(III) heme bond.[7, 52] It is well established that as the pH 
increases towards alkalinity, a bleaching of the 695 nm band is observed that is a consequence 
of the dissociation of a single proton resulting in the dissociation of the Met80 heme ligand and 
replacement by a Lys residue found in the 71-85 Ω-loop.[25-28, 53] The Lys bound form of 
Cc is referred to as the alkaline conformer.[53] For the A51V variant the apparent pKa for the 
alkaline conformer, determined by monitoring the bleaching of the absorbance band at 695 nm 
is 8.3 ± 0.1 (Fig. 5A), similar to the decrease of ~ 1 pH unit compared with WT hCc seen with 
the G41S and Y48H variants (Table 2). Thus, the three disease causing variants each stabilize 
the alkaline conformer to a similar degree relative to the WT protein. 
 The kinetics of the alkaline transition in mitochondrial Cc have been extensively 
studied and the mechanistic features can be described by a simple model depicted in Scheme 
1, whereby deprotonation of a group termed the trigger (pKH1), initiates a conformational 
change that leads to the substitution of the Met80 ligand with a Lys residue.[54]  
 
 
Scheme 1 
 
In Scheme 1, hCc-Htrig depicts the His/Met hexacoordinate protein with the trigger protonated, 
hCc the His/Met hexacoordinate protein with the trigger deprotonated, and hCc-Lys the 
hexacoordinate alkaline conformer of Cc with Lys now coordinated. KH1 and Kc are the 
equilibrium constants for the protonation/deprotonation and the conformational change, 
respectively, and kf1 and kb1 are the forward and backward rate constants, respectively. The 
ferric A51V variant was subjected to a series of stopped-flow pH jump experiments in the pH 
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range 7.0 to 10.0. where a single spectral transition was observed with the Soret band blue-
shifted and the 695 nm band bleached. We have adopted an analysis in which the full data set 
is subjected to singular value decomposition with no evidence for more than one phase. The 
transition therefore could be adequately fitted to a single exponential phase, with the 
determined rate constants (kobs1) increasing as expected with increasing pH (Fig. 5B). Similar 
behaviour has been previously reported for WT hCc and the G41S and Y48H variants.[25] 
Based on the model in Scheme 1, equation 5   
 
k=>?% = k>% + k@% 7 AB4AB4	C:   (5) 
 
can be used to fit the titration curve displayed by the A51V variant in Fig. 5B to yield the pKH1 
of the trigger. In equation 5, kobs1 takes the value kb1 at low pH and kb1 + kf1 at high pH values. 
The kf1 and pKH1 values for the A51V variant determined from the experimental data are 
reported in Table 2, and kb1 values have been estimated due to the difficulties in directly 
obtaining accurate values (as was also the case in previous work[25]). Comparison of the kf1 
and pKH1 values for the A51V variant with those determined for WT hCc and the G41S and 
Y48H variants are reported in Table 2, where it is apparent that the A51V variant lowers the 
pKH1 of the trigger by > 1 pH unit as noted with the other disease associated variants.[25] 
However, the pKH1 value for the A51V variant is slightly higher relative to the G41S and Y48H 
variants, but nevertheless continues the trend of substitutions in the 40-57 Ω-loop for making 
the trigger substantially easier to deprotonate. 
 At higher pH values (> 10) a second rapid phase (kobs2), in addition to the slow phase 
(kobs1) has been reported for hCc, several of its variants and horse heart Cc.[25, 55-58] For the 
A51V variant this rapid phase is also observed (Fig. 6A). The rate constant, kobs2, is associated 
with the formation of a transient spectrum characteristic of a high-spin (HS) ferric heme species 
having a prominent band at ~ 600 nm (Fig. 6B) and possessing long wavelength features that 
obscure the bleaching of the 695 nm band at some pH values. The spectrum decays to a final 
low-spin form typical of a ferric heme species with a Lys/His coordination (Fig 6B). It is 
notable for the A51V variant that this HS species is populated to a lesser extent than either the 
G41S and Y48H variants.[25] The kobs2 values decrease for the A51V variant until ~ pH 11, 
before rising steeply (Fig. 5C). At the lower pH values, the decrease in kobs2 values observed 
for the A51V variant is reminiscent of the WT protein (Fig. 5C), rather than the G41S and 
Y48H variants, where kobs2 values increase from pH 10 and above (Fig. 5C). Above pH 11 the 
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A51V variant behaves as the G41S and Y48H variants. The increasing kobs2 values for the 
G41S and Y48H variants implies that deprotonation precedes the conformational change that 
leads to the dissociation of the Met80 ligand from the heme iron.[25] This behaviour has been 
assigned to a coupling between a conformational change that exposes a group (not the trigger) 
that then undergoes deprotonation leading to the stabilization (or facilitation) of a HS heme 
species,[57] as represented in Scheme 2. 
 
 
Scheme 2 
 
In Scheme 2, -H represents the non-exposed group in the hexacoordinate His/Met form (hCc-
H) and the exposed group (after conformational change) in the pentacoordinate pCc-H form, 
with pCc representing the deprotonated HS heme form. Thus the A51V variant appears to be a 
combination of both the WT hCc (in the lower pH range) and the G41S and Y48H variants in 
the higher pH range, except that the pKH2 calculated for the G41S and Y48H variants of 11.0 
[25] is shifted to a higher value (~ 11.5) for the A51V variant. It should be noted for WT hCc 
the pKH2 cannot be calculated as the kobs2 values obtained at pH values > 12.5 are obscured by 
a more general denaturation of the protein as commented on previously.[25]  
 
Steady-state kinetics of CcO with the three THC4 causing 40-57 Ω-loop variants 
The respiratory function of Cc requires it to carry an electron from cytochrome c reductase 
(complex III) and deliver it to CcO (complex IV). Electrons enter the dinuclear CuA site of 
CcO and are passed to heme a and then to heme a3 and finally CuB, where a dioxygen molecule 
is reduced coupled to proton pumping across the membrane.[59, 60] At physiological pH, one 
might expect that lowering the pKa value from ~ 9.3 (WT hCc [5]) to ~ 8.4 (G41S and Y48H 
variants [5]) would lead to an increase in the fraction of the ferric Cc in the alkaline, non-
reducible form, and therefore to a change in the steady-state ratio of ferric/ferrous Cc when this 
is in turnover with its natural partner, CcO. To assess whether this is the case for the disease 
variants a series of steady-state experiments have been undertaken. These experiments monitor 
the redox state of WT hCc and variants while in turnover, receiving electrons from 
ascorbate/TMPD and donating these electrons to CcO and thence to oxygen. The methodology 
employed ensures that fully oxidised, activated (“pulsed”) CcO is presented with fully reduced 
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hCc in the presence of oxygen and a reductant system (sodium ascorbate and the mediator 
TMPD).[61] Figure 7A shows the result of such an experiment and displays spectra collected 
at known times. By increasing the rate of WT hCc reduction by ascorbate through addition of 
higher concentrations of TMPD, the steady-state reduction level of the whole system may be 
adjusted (Fig. S1). In Fig. 7A the spectra shown demonstrate that initially WT hCc is fully 
reduced and then rapidly donates electrons to oxidized CcO. The system now enters into 
steady-state (between 2 - 22 s) in which hCc is held at ~ 40 % reduced during turnover (Fig. 
7A and Fig. S1). Once the oxygen present is depleted, WT hCc (and CcO) is returned to the 
fully reduced state (31 s) by the excess reductant (Fig. 7A). The time course followed at 550 
nm, the α band of ferrous hCc, is shown in Figure 7B and reports that the redox state of hCc 
remains almost constant between 2 and 22 s, i.e. from the time the system enters steady-state 
until oxygen is exhausted (Fig. 7B). Closer examination, however, reveals that during this time 
there is a small decrease in the level of reduced WT hCc. This is better seen in the difference 
spectra shown in Fig. 7C in which the spectrum collected at 22 s is subtracted from that 
collected at 2 s. This difference spectrum is that of reduced minus oxidised WT hCc and shows 
that approximately 1.5 % of the protein became ferric in the time of the steady-state (between 
2 and 22 s).  
The same experiment was conducted using the G41S, Y48H and the A51V variants, 
and gave similar overall results but showed that in the variants the shift towards the ferric form 
was enhanced. This can be appreciated from Figure 8, where the difference spectra (between 
the start and end of the steady-state as illustrated in Fig. 7B) are compared for all variants. A 
clear trend in the drift toward the ferric form during steady-state may be discerned, in the order 
of Y48H (9.5 %) > G41S (3.5 %) > A51V (2.2 %) > WT (1.5 %). This order is the same as that 
already seen in the values of the Met80 dissociation rate constants (k1) determined from N3
– 
binding kinetics (Table 1). 
 
DISCUSSION 
The A51V substitution is located in a regular secondary structure motif (α2-helix), in contrast 
to the disease causing mutations at the 41 and 48 positions, which lie on a region of the 40-57 
Ω-loop devoid of secondary structure (Fig. 1). The α2-helix in hCc has the sequence 
TAA51NKNK, with Ala51 found at the N + 3 position. It is well documented that Ala has the 
highest helix propensity and is thus the most stabilising residue within an α-helix.[62] Val on 
the other hand is considered to be a destabilizing residue in an α-helix, with an estimated free 
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energy difference (∆∆G) from Ala (which is arbitrarily set at ∆G = 0.0 kcal/mol) of 0.61 
kcal/mol.[62] This destabilizing effect arises from an unfavourable change in side-chain 
conformational entropy when a helix is formed, with the loss greatest for amino acids with 
branched β-carbons allowing only the trans conformation in folded states.[63, 64] Globally, at 
least, the Ala to Val mutation causes the native structure to be destabilised to a similar degree 
as the G41S variant (Table 1), with the decreasing θ222/208 nm ratio having implications for a 
dynamic structure, relative to the WT protein. Based on helical-helical interactions within 
coiled-coil systems, a θ222/208 nm ratio of > 1.1 is indicative of quaternary structure formation 
(i.e. two α-helical monomers interacting) with θ222/208 nm ratios of 0.9 or less being indicative 
of isolated helices.[65-67] Moreover for helical proteins, the θ222/208 nm ratio can be associated 
with interhelical contacts and therefore can provide low-resolution information as to whether 
mutations cause a ‘loosening’ of the structure.[49] Based on our previous NMR studies to 
probe main chain dynamics in the WT protein and the G41S and Y48H variants,[5, 31] the 
θ222/208 nm ratios appear to correlate, in that the G41S was determined by NMR to be more 
dynamic than the WT, but less dynamic than the Y48H variant. Therefore based on the θ222/208 
nm ratio we suggest under non-denaturing conditions that the A51V variant is closer 
dynamically to the G41S variant than the Y48H variant.   
The m-value from chemical denaturation experiments is generally considered to give 
an estimate of the compactness or the degree of residual structure in the denatured state.[68, 
69] Table 1 reveals the m-value for the WT and variants decreases in the order WT > A51V ≅ 
G41S > Y48H. In yeast iso-1-Cc the m-value for the K54H variant is decreased relative to the 
WT protein [70] and this has been attributed to ligation by the His to the heme in the denatured 
state constraining the polypeptide and causing a more compact denatured state.[70] Neither the 
A51V or the G41S variants have substitutions that can coordinate the heme, yet in both cases 
the m-values decrease and notably more so than for substitutions in the 71-85 Ω-loop of 
hCc.[25] Thus the substitutions at the 41 and 51 positions contribute to destabilizing the 40-57 
Ω-loop (the lowest energy foldon of Cc), resulting in a more compact denatured state. A similar 
suggestion may be put forward for the Y48H variant, particularly now that by introducing a 
His this variant may behave similarly to the K54H variant of yeast iso-1 Cc.[70] However, the 
m-value for the Y48H variant is further decreased in respect to the A51V and G41S variants.[5] 
Solution state NMR studies under non-denaturing conditions with the Y48H variant are 
consistent with the presence of a partially unfolded form populated under non-denaturing 
conditions that bears the hallmarks of having an unfolded α2-helix.[5] The m-value can also 
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infer the occurrence of intermediates on the unfolding pathway.[71-73] For example, the 
decreased m-value of the K73H variant of yeast iso-1 Cc was not ascribed to His-heme ligation 
in the denatured state as for the K54H variant,[70] but rather to the existence of a native-like 
unfolding intermediate at low denaturant concentrations.[72] Notably, solution NMR studies 
with the G41S variant, albeit indicative of increased dynamics relative to WT hCc,[31] are not 
consistent with a partially unfolded state populated under non-denaturing conditions. 
Therefore, it is likely that the m-value for the G41S and the A51V variants reflect more compact 
denatured states, whereas the much lower m-value determined for the Y48H variant is 
consistent with the presence of a native-like intermediate accessible under non-denaturing 
conditions, with consequences for peroxidase activity.  
The Met80-off rate for the A51V variant estimated from N3
– binding kinetics lies 
between the WT hCc and the G41S variant (Table 1). The ratio WTKapp/
variantKapp reflects the 
ratio of equilibrium constants for dissociation and reassociation of the Met80 ligand 
(variantK/WTK). Thus based on the low Kapp (high affinity for N3
–) for the A51V variant the 
WTKapp/
A51VKapp is identical to the ratio for the Y48H variant indicating that the K values are 
similar and hence the population of the pentacoordinate forms in these two variants at 
equilibrium are equivalent. In spite of this, the peroxidase activity, while enhanced for the 
A51V variant is not at the Y48H level,[5] or for that matter the G41S variant,[5] where from 
the ratio of WTKapp/
G41SKapp the population of the G41S pentacoordinate form is lower.[31] 
Therefore, we suggest that the observed trend in peroxidase activity between variants is not 
purely a consequence of the population of the pentacoordinate form, but rather the rate constant 
(i.e. Met80-off rate, k1) for accessing the pentacoordinate state is a dominant factor (k1 values 
WT < A51V ≅ G41S < Y48H). In contrast, there is a lack of correlation between kf1 (the rate 
of formation of the alkaline form, Table 2) and k1, albeit that the transition to the alkaline form 
must incorporate the step in which Met80 dissociates. This implies that the rate determining 
step in the alkaline transition is not the Met80-off rate but rather subsequent steps involving 
the conformational transition and Lys binding to the ferric heme.  
Based on the above discussion the extent to which the native ferric hCc structure can 
facilitate peroxidase activity in these disease variants must be reconciled as an interplay 
between the Met80-off rate and tertiary structure dynamics. This view is further enhanced 
through recent studies with horse Cc using chemical denaturants to investigate peroxidase 
activity and ligand binding.[74] For the A51V and G41S variants the peroxidase activity whilst 
higher than WT hCc does not attain the Y48H variant levels, despite the pentacoordinate state 
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of the A51V variant being populated to the same extent as the Y48H variant. In the case of the 
latter the increased Met80-off rate and a highly dynamic solution state with ease of access to 
an unfolded state in which the 40-57 and 71-85 Ω-loops are highly perturbed[5] contribute to 
the higher peroxidase activity.  
Further insight into the peroxidase function of the variants may be obtained from the 
kinetics of the alkaline transition and the mechanistic framework in which four pentacoordinate 
forms can in theory be populated and illicit peroxidase activity (see the four corners of the front 
face of the cube in Figure 9 of Deacon et al.[25]). For the A51V variant the pKa and the pKH1 
values are essentially the same as the G41S and Y48H variants, implying greater ease of access 
to the pCc-H species (Scheme 2). As a Lys will be more protonated at pH 6.5, where peroxidase 
assays were monitored, this pentacoordinate species (pCc-H) will be more populated at 
equilibrium than the WT hCc.  
The interpretation of the second ionisation (pKH2) of the alkaline transition in relation 
to peroxidase activity is more difficult. For the A51V variant the pKH2 value is higher by ~ 0.5 
pH units than either the G41S and Y48H variants (Fig. 5C).[25] The group we and others have 
previously suggested to be responsible for stabilization of this HS form by deprotonation, is 
the proximal His18, which can lose a proton at high pH in the G41S and Y48H variants, but 
cannot do so in the WT hCc in the accessible pH range.[25] Bowler and colleagues have 
reported the existence of a water channel as a result of a repositioning of the 40-57 Ω-loop in 
a non-native state of Cc, allowing access to the proximal His18 ligand.[15] The pH profile in 
Figure 5C suggests that loss of a proton to the bulk solution is more difficult for the A51V 
variant than either the G41S or Y48H variants [25] yielding a higher pKH2. Although the A51V 
and Y48H variants have similar fractions of the ferric protein in the pentacoordinate state, the 
ease of which these forms can be stabilized by deprotonation (Scheme 2 and the mechanistic 
scheme (cube in Fig. 9) reported in[25]) appears to be subtly different. An explanation for this 
could manifest from differences in dynamics on the proximal side of the heme. We note that 
the substitutions at the 41 and 48 positions are at a juxtaposition to the 20’s Ω-loop compared 
to the 51 position (Fig. 1). It has been well documented that the disruption of a hydrogen-bond 
between His26 and Pro44 causes the subsequent release of the 20’s and 40’s Ω-loops leading 
to His18 being more accessible.[75] It could therefore be that the G41S and Y48H variants are 
more prominent than the A51V variant in perturbing this interaction and as a consequence instil 
a more dynamic proximal His side of the heme accounting for the subtilties in stabilizing the 
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HS form of the G41S and Y48H variants over the A51V variant, with consequences for H2O2 
access.   
Whilst extensive in vitro studies have been conducted on the hCc disease variants 
focusing on their apoptotic function, the effect of these mutations on respiratory chain function 
in vitro is lacking. From in vivo studies both the G41S and Y48H variants have been reported 
to induce a small defect in respiratory function based on measuring O2 consumption in cellular 
assays.[39] However, these studies do not report on the steady-state ratio of ferric/ferrous Cc 
when in turnover with CcO, which from the present and previous studies would be expected to 
vary in the disease variants When oxidised hCc and its variants are initially in the acid ferric 
form, i.e. the hexacoordinate (His/Met) conformer that possesses a 695 nm absorption band. 
Thereafter the ferric protein comes into conformational equilibrium between the acid and 
alkaline forms, the proportions of which depend on the ambient pH and the apparent pKa of the 
alkaline transition. The WT hCc has an apparent pKa of 9.3 (Table 2) while all the disease 
associated variants have apparent pKa values ~ 1 pH unit lower. Thus, at pH 7.4 (experimental 
pH of the turnover assay), approximately 1 % of the WT and 10 % of the variants should, at 
equilibrium, be in the alkaline form. This means that in turnover experiments, as illustrated in 
Fig. 7, there will be a thermodynamic driving force towards the ferric alkaline form (1 % WT 
and up to 10 % for the variants), which cannot be reduced by ascorbate until, in the dynamic 
equilibrium, it returns to the acid form that can be reduced. Similarly, in vivo reduction of the 
alkaline form by the bc1 complex occurs at the rate of transition from alkaline to acid forms of 
Cc. The extent to which this happens is dependent not only on the pKa for the alkaline transition 
but also on the electron flux through the respiratory chain, for example in circumstances in 
which the Cc is held in the ferrous state, then no alkaline form of the ferric protein is present. 
The experimental results are consistent with this expectation, except that not all the variants 
populate the alkaline form to the same extent (10 %, see above). This is because in the steady-
state the ferric forms do not come into true equilibrium and the rate of approach to this 
equilibrium is variant dependant. The relaxation time (τ) of the equilibrium between the acid 
and alkaline forms i.e. 1/τ = kf1 + kb1 is variant dependent and controls the kinetics of the 
approach to equilibrium and hence the extent to which the alkaline form is populated. These 
results therefore demonstrate that the disease related variants of hCc can have measurable 
effects on the mitochondrial electron-transfer system. The magnitude of any such effect must 
depend on the redox state of hCc and hence on the energetic state of the cell (i.e. 
coupled/uncoupled respiration) and on the time of residence of any given molecule of hCc in 
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the ferric state. These complex interactions cannot be readily assessed, but the overall effect of 
the 40-57 Ω-loop variants is clear. Thus, although not as important as the well documented 
effects such as enhanced peroxidase activity it is worth pointing out that such mutations may 
have small but possibly significant effects on the overall energetics of the cell. Within this 
context we see that A51V perturbs the redox state to a minor degree compared to the G41S and 
Y48H variants. 
 
CONCLUSIONS 
From in vitro studies all three hCc variants display physicochemical properties of the ferric 
form that influence peroxidase activity. The A51V variants displays features that we believe 
are consistent with a less dynamic native state than the Y48H variant, and is closer in dynamic 
properties to the G41S variant. Notably the A51V variant stands out in that despite having a 
population of the pentacoordinate form equal to the Y48H variant, peroxidase activity is the 
lowest of the three variants; a result we ascribe to the lower Met80 off-rate and subtle variations 
in main chain dynamics caused at the different mutation sites. The clinical features of the 
families expressing the G41S and Y48H variants both show similar reduced mean platelet 
counts with normal platelet volume and function.[76] However, the A51V family, whilst also 
displaying reduced mean platelet counts has in addition a platelet function defect.[76] Thus a 
distinction in clinical phenotypes between the G41S and Y48H variants versus the A51V 
variant is evident and may correlate to some of the physicochemical properties we elucidate 
here. The excursion into assessing the in vitro respiratory properties through monitoring the 
steady-state ratio of ferric/ferrous Cc when in turnover with CcO has illustrated that 
mitochondrial respiration can be compromised by mutations in the 40-57 Ω-loop, the effect 
being small, but depending on the respiratory state of the cell, possibly significant. 
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Table 1: Summary of thermodynamic and kinetic parameters for ferric WT hCc and the three 
40-57 Ω-loop variants determined by GuHCl denaturation (15 oC, 10 mM potassium 
phosphate, 50 mM potassium fluoride pH 6.5) and azide binding kinetics (25 oC, 50 mM MES 
pH 7.0).  
 
GuHCl denaturation 
protein ∆Gunf (kcal mol-
1) 
∆∆Gunf (kcal 
mol-1) 
m (kcal mol-1 
M-1) 
Cm (M) 
A51V 6.99 ± 0.16 3.66 ± 0.71 3.02 ± 0.07 2.32 ± 0.05 
G41S 6.75 ± 0.10a 3.90 ± 0.65 3.00 ± 0.10a 2.25 ± 0.05a 
Y48H 5.09 ± 0.16a 5.56 ± 0.71  2.57 ± 0.10a 1.98 ± 0.05a 
WT 10.65 ± 0.55a - 4.10 ± 0.25a 2.60 ± 0.05a 
Azide binding kinetics 
 
protein Kapp (M) k1 (s
-1) k-2 (s
-1) 
A51V 0.07 ± 0.06 33 ± 17d 7.6 ± 0.5d 
G41S 0.11 ± 0.01b 45 ± 18b 8.9 ± 0.3b 
Y48H 0.07 ± 0.01a 175 ± 94c,d 11.1 ± 1.1c,d 
WT 0.31 ± 0.03b 5.77 ± 1.5b 3.5 ± 0.4b 
aValues taken from ref. 5. 
bValues taken from ref. 31. 
cData taken from ref. 5 and refitted in the present study. 
dFor the A51V and Y48H variants, k-2 has been fitted using equation 4, and thereafter fixed to determine the errors 
on k1 (also using equation 4 with values reported in Table 1, see Materials and Methods). In addition, we have 
used the range of k-2 values reported in Table 1 to provide alternative commentary on the k1 errors. Thus for the 
A51V variant the range of k-2 yielded values of k1= 23 ± 8 s-1 (lower bound) and k1 = 64 ± 79 s-1 (upper bound). 
Likewise for the Y48H variant, k1 = 124 ± 49 s-1 (lower bound)and k1 = 329 ± 318 s-1 (upper bound). As k-2 and 
k1 are hyperbolically related, then we see as expected values of k-2 approaching its asymptotic value of 11.8 ± 0.6 
s-1 (see text), the error in k1 becomes large i.e. near the asymptotic value of k-2, small changes in k-2 lead to very 
large variation in k1.  
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Table 2: Summary of parameters determined for the alkaline transition of ferric WT hCc and 
the three 40-57 Ω-loop variants. 
 
 WT  A51V G41S Y48H 
pKa 9.3 ± 0.2
a  8.3 ± 0.1 8.5 ± 0.2a 8.4 ± 0.1a 
pKH1 12.0 ± 0.4
b 10.8 ± 0.1 10.5 ± 0.1b 10.4 ± 0.2b 
kf1 (s
-1) 17 ± 13b 8.3 ± 1.1 8.4 ± 1.3b 7.4 ± 1.4b 
kb1 (s
-1)c 0.034 ± 0.060 0.027 ± 0.012 0.084 ± 0.055 0.074 ± 0.051 
aData taken from ref. 5. 
bData taken from ref. 25. 
ckb1 was calculated from Kc (pKc = pKH1 – pKa) as kb1 = Kckf1. The error on kb1 was calculated from the error on 
Kc (noting that σpK = 0.434(σKc/Kc)) and the error on kf1 where σkb1 = Kcσkf1 + kf1σKc 
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Figure 1: X-ray structure of hCc (3ZCF)[23] and the location of the THC4 causing variants. 
The 40-57 Ω-loop (beige) showing the three residues, Gly41, Tyr48 and Ala51, depicted in 
stick representation, that are mutated to Ser, His and Val, respectively. The position of Lys100 
in the C-terminal helix is indicated in yellow. The heme and the axial iron ligands are shown 
in sticks and the 71-85 Ω-loop which communicates with the 40-57 Ω-loop is indicated. 
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Figure 2: Far-UV CD spectroscopy and chemical denaturation. A) Far-UV CD profile of the 
ferric A51V variant of hCc compared to the profiles for the WT protein and the G41S and 
Y48H variants (pH 6.5 and 15 oC). B) Plot of the fraction unfolded versus GuHCl concentration 
for the ferric A51V hCc variant (pH 6.5, 15 oC) with the solid-line representing a fit to the data 
using a two-state equilibrium unfolding equation (see Materials and Methods). The determined 
thermodynamic parameters are reported in Table 1. 
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Figure 3: Azide binding to the ferric A51V variant of hCc compared with data for the WT 
protein and G41S and Y48H variants[23, 31] at pH 7.0 and 25 oC. A) Amplitude changes from 
the reaction time-courses obtained using stopped-flow absorption spectroscopy at 420 nm 
plotted against azide concentration. Data are fitted to a hyperbola to yield Kapp values reported 
in Table 1. B) Rate constants (kobs) determined for azide binding with solid lines representative 
of fits to equation 4 with k1 and k-2 values reported in Table 1. C) The relationship between the 
azide dissociation rate constant (k-2) and the Met80-off rate (k1) with the line through the points 
fitted to a hyperbola. 
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Figure 4: Peroxidase activity at pH 6.5. The maximum peroxidation rates of ABTS with the 
various forms of ferric Cc. The error bars are the standard error from measurements carried out 
in triplicate. 
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Figure 5: The alkaline transition of the ferric A51V variant. A) The decrease in absorbance at 
695 nm plotted as a function of pH, with the solid-line representative of a fit to the data using 
a one-proton equilibrium equation with apparent pK695 values reported in Table 2. B) The pH 
dependence of kobs1 for the slow phase of the alkaline transition for WT hCc and the three 40-
57 Ω-loop variants determined from pH jump experiments. The lines are fits to the logarithmic 
transformation of equation 5 to yield the pKH1 (Table 2). C) The pH dependence of kobs2 for the 
alkaline transition plotted as a function of pH. The solid lines through the data points for hCc, 
and the A51V variant indicates the trends in the data, whereas for the G41S and Y48H variants 
the solid line represents a combined fit to a one-proton equilibrium equation to yield pKH2.  
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Figure 6: pH jump kinetics for the fast phase of the ferric A51V hCc variant at pH > 10.5. A) 
Single wavelength stopped-flow trace together with fit to a double-exponential on mixing ferric 
A51V hCc (pH 7) with an equal volume of a pH 11 buffer. The residuals of the double-
exponential fit are illustrated. B) Optical transitions between 480 and 700 nm from stopped-
flow spectroscopy taken at the indicated time during the pH jump experiment initiated as in 
(A). At t = 2.5 ms the spectrum represents the ferric hexacoordinate A51V variant, at t = 20 
ms, the HS pentacoordinate form and at t = 598 ms the final His/Lys alkaline form.  
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Figure 7: Redox states of hCc in turnover with CcO. A) Spectra collected at indicated times 
for the reactions of hCc (10 µM) in the presence of CcO (2.5 µM heme a), ascorbate (5 mM), 
TMPD (118 µM) and 135 µM oxygen ( all concentrations after mixing), pH 7.4 and 25 oC. B) 
The time course collected at 550 nm (α-band of ferrous hCc) showing the approach to steady-
state, and exit from steady-state. C) Difference spectrum between spectra taken at 2 s and 22 s 
(see B). 
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Figure 8: Comparison of difference spectra (2 s - 22 s) collected at pH 7.4 and 25 oC for the 
WT hCc and disease related variants. Each variant spectrum was normalised to a WT spectrum 
taken on the same day under the same conditions. The spectra have been adjusted to give the 
same absorbance at 700 nm. 
